Omkar Speciality Chemicals Limited carries a market capitalization of 70.17M, placing it among publicly traded companies globally. Its enterprise value stands at -20.12M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 70.17M |
| Enterprise Value | -20.12M |
The price-to-sales ratio is 925.82, and the price-to-book ratio stands at 0.37.
| PE Ratio | N/A |
| PS Ratio | 925.82 |
| PB Ratio | 0.37 |
| P/TBV Ratio | 0.41 |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
| EV / Sales | 5.81 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | N/A |
Omkar Speciality Chemicals Limited maintains a current ratio of 3.63, meaning it holds 3.6x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 3.63 |
| Quick Ratio | 3.63 |
| Debt / Equity | 16.58 |
| Debt / EBITDA | -1.78 |
| Interest Coverage | N/A |
| Return on Equity (ROE) | -7.72 |
| Return on Assets (ROA) | -2.60 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 0.01 |
Omkar Speciality Chemicals Limited's stock has declined approximately -44.64286% over the past 52 weeks. The 50-day moving average sits at 3.71, while the 200-day moving average is 5.08.
| Beta (5Y) | N/A |
| 52-Week Price Change | -44.64286% |
| 50-Day Moving Average | 3.71 |
| 200-Day Moving Average | 5.08 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Omkar Speciality Chemicals Limited generated 82,000.00 in revenue and converted that into -15.89M in net income, yielding earnings per share of -0.77. EBITDA reached -17.48M, while operating income came in at -17.48M.
| Revenue | 82,000.00 |
| Gross Profit | -4,000.00 |
| Operating Income | -17.48M |
| Pretax Income | -15.89M |
| Net Income | -15.89M |
| EBITDA | -17.48M |
| EBIT | -17.48M |
| Earnings Per Share (EPS) | -0.77 |
Omkar Speciality Chemicals Limited holds 127.09M in cash and equivalents against 31.05M in total debt, resulting in a net debt position of 27.24M. Total book value stands at 205.78M, with working capital of 92.21M providing operational flexibility.
| Cash & Cash Equivalents | 127.09M |
| Total Debt | 31.05M |
| Net Debt | 27.24M |
| Equity (Book Value) | 205.78M |
| Book Value Per Share | 9.97 |
| Working Capital | 92.21M |
Omkar Speciality Chemicals Limited operates with a gross margin of -4.88, reflecting its pricing power and cost economics. The operating margin of -21,318.29 and net profit margin of -19,374.39 provide insight into operational efficiency.
| Gross Margin | -4.88 |
| Operating Margin | -21,318.29 |
| Pretax Margin | -19,374.39 |
| Profit Margin | -19,374.39 |
| EBITDA Margin | -21,318.29 |
Omkar Speciality Chemicals Limited posts an Altman Z-Score of 0.29, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 0.29 |